{
    "2019-10-29": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Analysts Like Biogen's Chances of Getting Alzheimer's Drug Approved",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Alzheimer's",
                        "Drug",
                        "Approved"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "6 Stocks With Low Price-Sales Ratios",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Price-Sales",
                        "Ratios"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Incyte (INCY) Beats on Q3 Earnings & Sales, Ups Jakafi View",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Q3",
                        "Earnings",
                        "Sales",
                        "Jakafi"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "S&P Goes Where Itâ€™s Never Gone Before",
                "features": {
                    "keywords": [
                        "S&P",
                        "record high",
                        "market milestone"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Eli Lilly and Company -- Moody's assigns A2 rating to Eli Lilly's euro notes; stable outlook",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Moody's",
                        "A2 rating",
                        "euro notes",
                        "stable outlook"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "5 Lagging Blue Chips That Can Lead as Investors Turn Bearish",
                "features": {
                    "keywords": [
                        "Blue Chips",
                        "Bearish",
                        "Investors"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}